// App-Quantinova.ai

: Evaluation of novel LOXL2-selective inhibitors in models of pulmonary fibrosis

Researchers

Presenter

  • James Roberts

Principal Investigators

  • Victoria Tear

  • Kerry Lunn

  • Lucy Cao

  • James Murphy

  • Chiko Shimbori

  • Jewel Imani

  • Karun Tandon

  • Ehab Ayaub

  • Mark Jones

  • Donna Davies

  • Wolfgang Jarolimek

  • Kjetil Ask

  • Jack Gauldie

  • Martin Kolb

  • Phillip Monk

Medical Centers

  • Synairgen Research Limited, Southampton, United Kingdom.

  • Pharmaxis Ltd,Frenchs Forest,Australia

  • University of Southampton, Southampten, United Kingdom

Locations

  • United Kingdom

  • Australia

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Pulmonary fibrosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved